Missling just indicated planning to meet with FDA
Post# of 1460
(Total Views: 428)
Posted On: 12/28/2020 4:39:31 PM
Missling just indicated planning to meet with FDA to discuss accelerated approval...meaning approval based upon the recent topline results from the Phase 2....same thing happened with Sarepta. Hopefully, FDA has learned from the Sarepta experience and will move quickly to help these girls!
(2)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼